The regulation of Sema4D exodomain shedding by protein kinase A in platelets

T Chen1, D Z Xu1, Q Li1

  • 1a Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, MOH Key Lab of Thrombosis and Hemostasis, Jiangsu Institute of Hematology, Jiangsu Key Lab of Preventive and Translational Medicine for Geriatric Diseases, Soochow University , Suzhou , China.

Platelets
|November 5, 2016
PubMed

Insights

Protein kinase A (PKA) regulates Sema4D shedding from platelets. PKA inhibition promotes shedding via ADAM17, while PKA activation inhibits it, revealing a novel regulatory pathway.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Sema4D is expressed on platelet plasma membranes and can be cleaved by ADAM17.
  • This shedding produces biologically active exodomain fragments and membrane-associated remnant fragments.
  • Calmodulin modulates this cleavage process.

Purpose of the Study:

  • To investigate the role of protein kinase A (PKA) in Sema4D shedding from platelets.
  • To elucidate the regulatory mechanisms of Sema4D shedding.

Main Methods:

  • Pharmacological inhibition and activation of PKA using H89.
  • Analysis of Sema4D shedding and its association with ADAM17 and calmodulin.
  • Identification of cleavage sites within the juxtamembrane region.

Main Results:

  • PKA inhibition with H89 induced Sema4D exodomain shedding.
  • PKA activation inhibited agonist-initiated Sema4D shedding.
  • Shedding induced by PKA inhibition is ADAM17-mediated and does not involve calmodulin dissociation.

Conclusions:

  • PKA plays a significant role in regulating Sema4D shedding in platelets.
  • PKA inhibition represents a novel mechanism for inducing Sema4D shedding.
  • ADAM17 mediates variable cleavages in the juxtamembrane region during Sema4D shedding.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K